APA (7th ed.) Citation

Bidard, F., Mathiot, C., Degeorges, A., Etienne-Grimaldi, M., Delva, R., Pivot, X., . . . Pierga, J. (2010). Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy. Annals of Oncology, 21(9), 1765. https://doi.org/10.1093/annonc/mdq052

Chicago Style (17th ed.) Citation

Bidard, F.-C, et al. "Clinical Value of Circulating Endothelial Cells and Circulating Tumor Cells in Metastatic Breast Cancer Patients Treated First Line with Bevacizumab and Chemotherapy." Annals of Oncology 21, no. 9 (2010): 1765. https://doi.org/10.1093/annonc/mdq052.

MLA (9th ed.) Citation

Bidard, F.-C, et al. "Clinical Value of Circulating Endothelial Cells and Circulating Tumor Cells in Metastatic Breast Cancer Patients Treated First Line with Bevacizumab and Chemotherapy." Annals of Oncology, vol. 21, no. 9, 2010, p. 1765, https://doi.org/10.1093/annonc/mdq052.